Peptide Dosages

Contents

Quickstart Highlights

BPC157 + TB500 (20mg) dosage protocol is designed to support tissue repair, enhance recovery, and promote regenerative benefits through daily or phased subcutaneous injections

  • Often used for injury recovery, tendon/ligament health, and general tissue support
  • Typical schedule involves once-daily or a few times per week injections
  • Two common approaches: Standard (lower daily dose) and Advanced (higher daily dose)
  • Reconstitute to a practical concentration for accurate dosing
  • Store lyophilized in the freezer; reconstituted in the refrigerator
BPC157 + TB-500 (20mg Blend Vial)
📘 Important: Before viewing any protocol, please consult our Prep & Injection Guide for essential preparation and safety instructions.

Dosing & Reconstitution Guide

Educational guide for reconstitution and daily dosing

Standard / Gradual Approach (3 mL = ~6,667 mcg/mL)

Week Daily Dosage (mcg) Units (per injection)
Weeks 1–4 250 mcg ~4 units

Suitable for moderate tissue support over four weeks. Reconstitute with 3 mL of bacteriostatic water to achieve a ~6,667 mcg/mL solution.
Note: 250 mcg per day at this concentration is around 4 units. Consider using smaller insulin syringes (50u or 30u) for precise measurement.

  1. Draw 3.0 mL of bacteriostatic water into a sterile syringe.
  2. Slowly inject the water along the vial wall to minimize foam.
  3. Gently swirl—avoid vigorous shaking.
  4. Store the reconstituted solution at 2–8 °C (refrigerator), protected from light.

Advanced / Aggressive Approach (3 mL = ~6,667 mcg/mL)

Week Daily Dosage (mcg) Units (per injection)
Weeks 1–4 500 mcg ~8 units

A more robust approach beneficial for higher dosing. Reconstitute with 3 mL of bacteriostatic water to create a ~6,667 mcg/mL solution.
Note: 500 mcg daily for 4 weeks totals ~14 mg, so one 20mg vial generally covers a 4-week advanced cycle with some leftover.

  1. Draw 3.0 mL of bacteriostatic water into a sterile syringe.
  2. Slowly inject the water to reduce foaming and peptide agitation.
  3. Gently roll/swirl the vial—no vigorous shaking.
  4. Store the reconstituted solution at 2–8 °C (refrigerator), protected from light.
Note: This guide is for educational purposes only. Always consult a qualified healthcare professional.

Supplies Needed

Ensure you have these on hand for a 4-week (or longer) cycle.

  • Peptide Vials:
    • 4 wks @ 250 mcg/day ≈ 1 vial (20 mg total)
    • 4 wks @ 500 mcg/day ≈ 1 vial (some leftover)
    (Adjust if planning higher doses or extended duration)
  • Insulin Syringes: 1 syringe per injection day
  • Bacteriostatic Water: 1× 30ml
  • Alcohol Swabs: 1 box

Protocol Overview

A concise summary of daily injection protocols for tissue support and recovery.

  • Goal: Promote healing, regeneration, and inflammation reduction
  • Schedule: Daily subcutaneous injections for 4+ weeks
  • Dose Range: 250 mcg to 500 mcg daily, as tolerated
  • Reconstitution: Up to 3 mL to facilitate straightforward dosing
  • Storage: Keep lyophilized vials frozen; refrigerate after reconstitution

Dosing Protocol

Suggested daily injection approach for effective tissue healing support.

  • Daily Dose: 250 mcg (standard) or 500 mcg (advanced)
  • Frequency: Inject once daily subcutaneously
  • Cycle Length: 4 weeks minimum; can extend to 8+ weeks
  • Multiple Vials: One 20mg vial typically covers 4 weeks at advanced dosing
  • Timing: Any time of day; consistency is key

Storage Instructions

Proper storage ensures peptide integrity.

  • Lyophilized: Freeze until mixing (−20°C or similar)
  • Reconstituted: Refrigerate at 2–8°C
  • Use within 30 days of reconstitution
  • Avoid repeated freeze-thaw cycles

Important Notes

Practical tips to enhance safety and efficacy.

  • Use new, sterile syringes for each injection & rotate injection sites.
  • Maintain consistency; daily injections support steady peptide levels.
  • Monitor for adverse reactions; consult a professional if concerns arise.
  • Track progress throughout the protocol, adjusting dosage as recommended.

How This Works

BPC157 and TB500 (Thymosin Beta-4) target multiple aspects of tissue repair and regeneration.

  • BPC157: May aid in repairing tendons, ligaments, and muscle tissues
  • TB500: Helps regulate actin, boosting cell migration and recovery
  • Together, they synergistically support wound healing and reduce inflammation

Potential Benefits & Side Effects

Most users observe better healing and reduced downtime, though responses vary.

  • Enhanced tissue repair for injuries or chronic issues
  • Possible reductions in inflammation and discomfort
  • Mild side effects might include redness at injection site or fatigue
  • Rarely, headaches or dizziness can occur

Injection Technique

General subcutaneous guidance from clinical best-practice resources.

  • Clean the vial stopper and skin with alcohol; allow to dry[5].
  • Pinch a skinfold; insert the needle at 45–90° into subcutaneous tissue[5][6].
  • Do not aspirate for subcutaneous injections; inject slowly and steadily[7].
  • Rotate sites systematically (abdomen, thighs, upper arms) to avoid lipohypertrophy[5][6].
  • Do not rub the injection site; apply light pressure with gauze if needed.

Lifestyle Factors

Maximize peptide effectiveness with supportive habits.

  • Combine with a balanced, nutrient-dense diet
  • Incorporate physical therapy or regular activity for injury recovery
  • Ensure adequate rest and manage stress levels

Recommended Source

We recommend Pure Lab Peptides for high-purity 5-Amino-1MQ (10 mg).

Why Pure Lab Peptides?

  • Start: 150 mcg daily for 2 weeks to assess tolerance.
  • Mid-Phase: Increase to 300 mcg daily for weeks 3–4.
  • Target: 600 mcg daily by weeks 5–8.
  • Frequency: Once per day (subcutaneous).
  • Cycle Length: 8 weeks minimum; may extend based on research goals.
  • Timing: Any consistent time; rotate injection sites.

Important Note

This content is intended for therapeutic educational purposes only and does not constitute medical advice, diagnosis, or treatment. All current data come from preclinical research in cells and animal models; no human clinical trials have been published to date.

References


PubMed Central
– Peptide-based tissue healing study

PubMed Central
– BPC-157 pharmacokinetics research

PubMed Central
– Wound healing peptides review

BEI Resources (NIH)
– Peptide standard documentation
PubMed Central
– Thymosin studies in clinical settings
PubMed
– BPC-157 experimental analysis
McGill University
– Article on peptide self-experimentation
WADA (World Anti-Doping Agency)
– TB-500 metabolism investigation